Hepatocellular carcinoma and cholangiocarcinoma - Different prognosis, pathogenesis and therapy;Hepatozelluläres Karzinom und Cholangiokarzinom - Unterschiedliche Prognose, Pathogenese und Therapie

Zentralblatt fur Chirurgie

Volumn 132, Issue 4, 2007, Pages 300-305

  Tischoff, I ^a   Tannapfel, A ^a,b  

^a INSTITUT FÜR PATHOLOGIE   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cholangiocarcinoma; Combined hepatocellular cholangiocarcinoma; Hepatocellular carcinoma; Liver tumours

Indexed keywords

EID: 34548416111     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981195     Document Type: Article

References (33)

1. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-655
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatits B virus: a prospective study of 22700 men in Taiwan. Lancet 1981; 2: 1129-1133
3. Berman MA, Burnham JA, Sheahan DG. Fibrolamellr carcinoma of the liver: an immunhistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988; 19: 784-794
4. Chapman RW, Risk factors for biliary tract carcinogenesis, Ann Oncol 1999; 10 (Suppl 4): 308-311
5. Collier J, Sherman M. Screening for hepatocellular carcinoma, Hepatology 1998; 27: 273-278
6. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, Houghton M. Prevalence of antibodies of hepatits C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-1008
7. Goodman ZD, Ishak KG, Langloss JM, Sesterhenn IA, Rabin L Combined hepatocellular-cholangiocarcinoma. A histological and immunhistochemical study. Cancer 1985; 55: 124-135
8. Hamilton SR, Aaltonen IA. WHO: Pathology and Genetics. Tumors of Digestive System. IARC Press, Lyon 2000; 173-180
9. Harder J, Blum HE. Cholangiocarcinoma, Schweiz Med Rundsch Prax 2002; 91: 1352-1356
10. Hewitt PM, Krige JE, Bornmann PC, Terblanche J. Choledochal cysts in adults. BrJ Surg 1995; 82: 382-385
11. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 2004; 24: 189-199
12. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of defined population from a lowendemicity area. Br J Cancer 1996; 73: 128-132
13. Kubo S, Kinoshita H, Hirohashi K, Hamba H. Hepatolithiasis associated with cholangiocarcinoma. World J Surg 1995 ; 19: 637-641
14. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤ 4 cm. Gastroenterology 2004; 127: 1714-1723
15. Lipsett PA, Pitt HA, Colombani PM, Boitnott JK, Cameron JL. Choledochal cyst disease. A changing pattern of presentation. Ann Surg 1994; 220: 644-652
16. Liu D, Momoi H, Li L, Ishikawa Y, Fukumoto M. Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma, Int J Cancer 2002; 102: 366-371
17. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699
18. Ng IQ, Shek TW, Nicholls J, Ma LT. Combined hepatocellular- cholangiocarcinoma: A clinicopathological study. J Gastroenterol Hepatol 1998; 13: 34-40
19. Newberne PM. Chemical carcinogenesis: Mycotoxins and other chemicals to which humans are exposed. Semin Liver Dis 1984; 4: 122-135
20. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. IntJ Cancer 2000; 94: 153-156
21. Polio J, Enriquez RE, Chow A, Wood WM, Atterbury CE. Hepatocellular carcinoma in Wilson's disease. J Clin Gastroenterol 1989; 11; 220-224
22. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled study of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130
23. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigematsu T. Hepatiti B and C virus, Clonorchensis sinensis for risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933-940
24. th ed. Wiley-Liss., New York 2002
25. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. Tumours of liver and pancreas. A clinicopathological stuy of combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11: 758-764
26. Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mössner J, Wittekind C. Expression of p73, a novel protein related to the p 53 tumor suppressor, p 53 and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer 1999; 80: 1069-1074
27. Tannapfel A, Wittekind C. Anatomie und Pathologie des intrahepatischen und extrahepatischen Gallengangskarzinoms. Pathologie 2001; 21: 114-123
28. Tannapfel A, Wittekind C. Gallenblasen- und Gallengangskarzinom. Internist 2004; 45: 33-41
29. Tannapfel A. Hepatitis-B-Virus-assoziiertes hepatozelluläres Karzinom. In: HeintgesT, Häussinger D (Hrsg). Hepatitis B: Infektion Therapie -Prophylaxe. 1. Aufl. Thieme Verlag, Stuttgart, New York 2006; 172-181
30. Watanapa P. Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg 1996; 83: 1062-1064
31. Wittekind C. Hepatocellular carcinoma and cholangiocarcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE (eds). Prognostic Factors in Cancer. Springer, Berlin 1995; 88-93
32. Wittekind C, Tannapfel A. Tumoren der Leber. In: Doerr W, Seifert G, Uehlinger E (Hrsg). Spezielle Pathologische Anatomie: Pathologie der Leber und Gallenwege, 2. Aufl. Springer, Berlin, Heidelberg, New York, Tokyo 2000; 871-929
33. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127: 72-78